<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Hemoglobin patterns in common hemoglobinopathies</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Hemoglobin patterns in common hemoglobinopathies</h1>
<div class="graphic"><div class="figure"><div class="ttl">Hemoglobin patterns in common hemoglobinopathies</div><div class="cntnt"><table cellspacing="0"><colgroup span="9" width="11%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1" rowspan="2">Condition</td> <td class="subtitle1" rowspan="2">Genotype</td> <td class="subtitle1" rowspan="2">Neonatal screening*</td> <td class="subtitle1" rowspan="2">By age 6 weeks</td> <td class="subtitle1" colspan="5">Older children (≥5 years), adolescents, and adults</td> </tr> <tr class="divider_bottom"> <td class="subtitle2">Hb A<br/> (%)</td> <td class="subtitle2">Hb A<sub>2</sub><br/> (%)</td> <td class="subtitle2">Hb F<br/> (%)</td> <td class="subtitle2">Hb S<br/> (%)</td> <td class="subtitle2">Hb C<br/> (%)</td> </tr> <tr class="divider_bottom"> <td>Normal</td> <td>AA</td> <td>FA</td> <td>FA or AF</td> <td>95 to 98</td> <td>2 to 3</td> <td>&lt;2</td> <td>0</td> <td>0</td> </tr> <tr class="divider_bottom"> <td>Beta thalassemia trait</td> <td>A/(β<sup>0</sup> or β<sup>+</sup>)</td> <td>FA</td> <td>FA</td> <td>90 to 95</td> <td>&gt;3.5 (unless due to δβ; can be normal or lower)</td> <td>1 to 3 (significantly higher if due to δβ deletion)</td> <td>0</td> <td>0</td> </tr> <tr class="divider_bottom"> <td>Sickle cell trait</td> <td>AS</td> <td>FAS</td> <td>FAS</td> <td>50 to 60</td> <td>&lt;3.5</td> <td>&lt;2</td> <td>35 to 45; may be lower if concomitant alpha thalassemia</td> <td>0</td> </tr> <tr class="divider_bottom"> <td>Homozygous sickle cell (Hb SS) disease</td> <td>SS</td> <td>FS</td> <td>FS</td> <td>0</td> <td>&lt;3.5 but may be increased with concomitant α-thalassemia. May be falsely elevated when measured by HPLC</td> <td>5 to 15; may be higher in rare cases</td> <td>85 to 95</td> <td>0</td> </tr> <tr class="divider_bottom"> <td>Sickle-β<sup>0</sup> thalassemia</td> <td>Sβ<sup>0</sup></td> <td>FS</td> <td>FS</td> <td>0</td> <td>&gt;3.5 but may be falsely elevated when measured by HPLC</td> <td>2 to 15</td> <td>80 to 92</td> <td>0</td> </tr> <tr class="divider_bottom"> <td>Sickle-β<sup>+</sup> thalassemia</td> <td>Sβ<sup>+</sup></td> <td>FSA or FS<sup>¶</sup></td> <td>FSA</td> <td>3 to 30</td> <td>&gt;3.5 but may be falsely elevated when measured by HPLC</td> <td>2 to 10</td> <td>65 to 90</td> <td>0</td> </tr> <tr class="divider_bottom"> <td>Hb SC disease</td> <td>SC</td> <td>FSC</td> <td>FSC</td> <td>0</td> <td>&lt;3.5</td> <td>1 to 5; may be higher in rare cases</td> <td>45 to 50</td> <td>45 to 50</td> </tr> <tr class="divider_bottom"> <td>Hb CC disease<sup>Δ</sup></td> <td>CC</td> <td>FC</td> <td>FC</td> <td>0</td> <td>&lt;3.5</td> <td>&lt;2</td> <td>0</td> <td>95</td> </tr> <tr> <td>Hb C trait<sup>Δ</sup></td> <td>AC</td> <td>FAC</td> <td>FAC</td> <td>50 to 60</td> <td>&lt;3.5</td> <td>&lt;2</td> <td>0</td> <td>40 to 50</td> </tr> </tbody></table></div><div class="graphic_lgnd">Hemoglobin may be analyzed by one or more of several separation techniques including HPLC, capillary electrophoresis, isoelectric focusing, or gel electrophoresis. Numbers are approximate and may vary depending on the laboratory method used. Transfusions will affect the percentages measured. Levels of Hb A2 can be affected by thalassemia, iron deficiency, and various other conditions and cannot be used to make a diagnosis of Hb S-beta thalassemia. In selected cases, DNA analysis may be helpful. Refer to UpToDate for discussions of hemoglobin analysis and diagnosis of specific syndromes.</div><div class="graphic_footnotes"><p>Hb: hemoglobin; Hb A: adult hemoglobin; Hb F: fetal hemoglobin; δβ: delta-beta; HPLC: high-performance liquid chromatography; DNA: deoxyribonucleic acid.</p>
<p>* The neonatal screening patterns list the different hemoglobins in order of abundance. As an example, the FAS pattern has the greatest amount of Hb F, followed by Hb A, followed by Hb S.</p>
<p>¶ In sickle-β<sup>+</sup> thalassemia, the quantity of Hb A at birth may be insufficient for detection.</p>
Δ In Hb C trait, concomitant alpha thalassemia variants lower the percentage of Hb C, and Hb C levels &lt;40% after iron deficiency is excluded or corrected may indicate a two-gene deletion at the alpha locus. Hb C trait plus a beta thalassemia variant could be misdiagnosed as Hb CC disease.</div><div class="graphic_reference"><p>Adapted from: Sickle cell disease in children and adolescents: Diagnosis, guidelines for comprehensive care, and care paths and protocols for management of acute and chronic complications. Revised at the Annual Meeting of the Sickle Cell Disease Care Consortium, Sedona, AZ, November 10-12, 2001.</p>
With additional data from: Bain BJ. Sickle cell haemoglobin and its interactions with other variant haemoglobins and with thalassaemias. In: Haemoglobinopathy Diagnosis, 2nd ed, Wiley-Blackwell, Oxford, 2005.</div><div id="graphicVersion">Graphic 116210 Version 10.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
